Skip to main content

Advertisement

Table 4 Results of genotyping of PALB2 mutation carriers

From: A novel germline PALB2 deletion in Polish breast and ovarian cancer patients

Proband no. Marker position bp D16S403 22,977,651 D16S481 23,188,290 PALB2 23,554,483* D16S417 23,717,034
293 Ov. Ca. 2, 3 1, 2 c.509-510delGA 2, 4
375 Ov. Ca. 2, 6 1, 2 c.509-510delGA 2, 4
ZB649 Control 4, 3 1, 2 c.509-510delGA 3, 4
802 Br. Ca. 1, 6 3, 2 c.509-510delGA 2, 4
2076 Br. Ca. 4, 5 1, 1 c.509-510delGA 2, 1
893 Br. Ca. 4, 3 1, 2 c.509-510delGA 3, 4
1540 Br. Ca. 4, 3 1, 1 c.509-510delGA 2, 4
  1. Alleles for each microsatellite marker were numbered according to the size. Ov. Ca. - ovarian cancer patients; Control - a PALB2 mutation carrier from the control group; Br. Ca. - breast cancer patients
  2. * the position of PALB2 gene on chromosome 16 (NCBI reference sequence: NT_010393.16); the position of the deletion is 23,587,357 bp